Institute for Health Excellence in Health Equity, New York University Grossman School of Medicine, United States of America; Department of Population Health, New York University Grossman School of Medicine, United States of America.
Department of Medicine, Division of General Internal Medicine at San Francisco General Hospital, University of California San Francisco, United States of America; UCSF Center for Vulnerable Populations, San Francisco General Hospital, United States of America.
Contemp Clin Trials. 2023 Mar;126:107112. doi: 10.1016/j.cct.2023.107112. Epub 2023 Feb 3.
Self-measured blood pressure monitoring (SMBP) is essential to effective management of hypertension. This study aims to evaluate effectiveness and implementation of SMBP that leverages: cellular-enabled home BP monitors without a need for Wi-Fi or Bluetooth; simple communication modalities such as text messaging to support patient engagement; and integration into existing team-based workflows in safety-net clinics.
This study will be conducted with patients in San Francisco who are treated within a network of safety-net clinics. English and Spanish-speaking patients with diagnosed hypertension will be eligible for the trial if they have recent BP readings ≥140/90 mmHg and do not have co-morbid conditions that make home BP monitoring more complex to manage. This study will implement a three-arm randomized controlled trial to compare varying levels of implementation support: 1) cellular-enabled BP monitors (with minimal implementation support), 2) cellular-enabled BP monitors with protocol-based implementation support (text reminders for patients; aggregated BP summaries sent to primary care providers), and 3) cellular-enabled BP monitors and pharmacist-led support (pharmacist coaching and independent medication adjustments).
For the main analysis, we will use mixed effects linear regression to compare the change in primary outcome of systolic BP. Secondary outcomes include BP control (<140/90 mmHg), medication intensification, patient-reported outcomes, and implementation processes (i.e., engagement with the intervention).
This study will design and test a digital health intervention for use in marginalized populations treated within safety net settings, evaluating both effectiveness and implementation to advance more equitable health outcomes.
自我血压监测(SMBP)对于有效管理高血压至关重要。本研究旨在评估利用:无需 Wi-Fi 或蓝牙的带蜂窝功能的家用血压监测仪;支持患者参与的简单通信方式,如短信;并整合到安全网诊所现有的基于团队的工作流程中,来实现 SMBP 的效果和实施。
本研究将在旧金山的安全网诊所接受治疗的患者中进行。如果患者有近期血压读数≥140/90mmHg,且无使家庭血压监测更难管理的合并症,则符合该试验的条件。本研究将实施一项三臂随机对照试验,以比较不同程度的实施支持:1)带蜂窝功能的血压监测仪(仅提供最低限度的实施支持);2)带基于协议的实施支持的带蜂窝功能的血压监测仪(向患者发送短信提醒;将汇总的血压摘要发送给初级保健提供者);3)带蜂窝功能的血压监测仪和药剂师主导的支持(药剂师指导和独立药物调整)。
对于主要分析,我们将使用混合效应线性回归来比较收缩压主要结局的变化。次要结局包括血压控制(<140/90mmHg)、药物强化、患者报告的结果和实施过程(即干预的参与度)。
本研究将设计和测试一种用于安全网环境中治疗的边缘化人群的数字健康干预措施,评估有效性和实施情况,以促进更公平的健康结果。